What You Are Looking At
A result letter from a hepatitis C test is not a diagnosis letter. It is a report of what a laboratory found in a blood sample, translated into clinical language that laboratories use to communicate with clinicians — not with patients. The fact that it reached you first is a feature of how postal and electronic results systems work, not a signal that you are expected to interpret it alone. That interpretation is your clinician's job, and it will happen. What follows is a plain-language account of the words most commonly found on these letters, so that the time between reading the letter and sitting with your clinician is less unsettling.

One preliminary point: result letters vary by country, by laboratory, and by which test was run. Not every term below will appear on yours, and yours may contain terms not covered here. Treat this as background reading, not as a decoder for your specific result.
Terms used here
- Reactive
- antibody test found immune proteins; does not confirm active infection
- Non-reactive
- antibodies not found at detectable level
- Detected / Not detected
- RNA test language; indicates whether virus is currently present
- Equivocal / Indeterminate
- result in uncertain range; repeat test needed
- HCV
- abbreviation for hepatitis C virus; appears on most letters
- Genotype
- numbered classification of viral strain; relevant to treatment planning
- Viral load
- quantity of viral RNA per millilitre of blood, in IU/mL; not a severity score
- ALT / AST
- liver enzymes; elevated levels suggest liver cells under stress
- Reference range
- laboratory's typical values; flags (H/L) are prompts, not diagnoses
The Vocabulary of Screening and Initial Results
Reactive. This word appears on antibody test results. An antibody test does not look for the virus itself — it looks for proteins the immune system produced in response to a past encounter with the hepatitis C virus. "Reactive" means the laboratory found those antibodies. It does not mean the virus is currently present. Antibodies persist in the blood long after an infection has cleared, whether it cleared on its own or following treatment. A reactive antibody result, on its own, is the beginning of an investigation — not the end of one.
Non-reactive. The result when the antibody test found no antibodies, or found them below the threshold the laboratory uses to call a result positive. In most circumstances this means either the person was not infected or, if a very recent exposure is possible, that the test was taken before antibodies had time to develop. The period during which a person is infected but antibodies have not yet appeared has its own name: the window period.
Detected / Not detected. These words appear on RNA tests — the second kind of test in hepatitis C investigation. An RNA test looks directly for the virus's genetic material in the blood. "Detected" means viral RNA was found, which indicates the virus is currently present. "Not detected" means it was not found at the sensitivity level the laboratory was working to. On a result letter that follows a reactive antibody test, "not detected" generally means the immune system cleared the infection at some point in the past. On a result letter following successful treatment, "not detected" carries a specific clinical meaning that your clinician will explain.
Equivocal / Indeterminate. Some result letters use these words instead of a clear reactive or non-reactive finding. They indicate that the result fell in a range the laboratory could not confidently assign to either side of its threshold. This happens. It is not alarming in itself — it means a repeat test is needed. Your clinician will arrange that.
Antibody titre. Occasionally a result includes a number alongside the antibody finding — a measure of how strongly reactive the sample was. This number is not a useful guide to whether active infection is present, how advanced anything is, or what to do next. Clinicians are aware it can look alarming; it is laboratory information for laboratory and clinical purposes.
HCV antibody. HCV stands for hepatitis C virus. You will see it on most result letters as shorthand. It means nothing different from "hepatitis C" — it is simply the formal abbreviation.
Genotype. If viral RNA is detected, a further test can identify which genetic strain of the hepatitis C virus is present. There are several main genotypes, numbered. Knowing the genotype matters to clinicians because different genotypes respond somewhat differently to treatment options — this is one of the reasons why one approach does not suit every case. Genotype information appears on some result letters, particularly when the RNA test and genotyping are processed together. It looks like a number, sometimes followed by a letter: "genotype 1a", "genotype 3". The number itself has no intuitive meaning — it is a classification marker, not a measure of severity.
Viral load. When viral RNA is detected, the test can also count approximately how much of it is present. This is the viral load, usually expressed in IU/mL — International Units per millilitre of blood. A high number and a low number do not straightforwardly mean "worse" and "better" in the way that might feel intuitive. Viral load at diagnosis tells clinicians something useful about the infection; viral load measurements taken during and after treatment tell them something quite different. The number on your letter is one data point in a clinical picture your clinician is assembling. It is not a score out of ten for how unwell you are.
ALT / AST. These abbreviations refer to liver enzymes. ALT is alanine aminotransferase; AST is aspartate aminotransferase. Liver cells contain these enzymes, and when liver cells are under stress, the enzymes leak into the bloodstream in greater amounts. An elevated ALT or AST on a result letter signals that the laboratory found more of these enzymes than a reference range suggests is typical. This is one way clinicians get an early, indirect sense of how the liver is responding to the presence of the virus. You may see a reference range printed alongside the number on your letter — these ranges vary between laboratories, which is another reason a clinician is the right person to interpret them.
Reference range / Normal range. Many laboratory reports include a column or bracket showing the range the laboratory considers typical for a given measurement. A result outside that range is flagged, often with an asterisk or the letter H (high) or L (low). These flags are not diagnoses. They are prompts — for clinicians, not for patients interpreting alone.
Specimen: serum / plasma / whole blood. A note about what type of sample was tested. Serum and plasma are both derived from blood; the difference reflects how the sample was processed before testing. This detail rarely matters to the patient reading the letter, but seeing it can be confusing if you were expecting just to see "blood."
| "A result letter is a document produced for clinical communication — reading it without clinical training is like reading a structural engineer's survey report on a building." | In short: an antibody test shows only that your immune system has responded to the virus; an RNA test shows whether the virus is currently present; a genotype identifies the strain; and a viral load measures the quantity of virus, not how severe the infection is. |
How the Pieces Fit Together
Understanding individual terms is one thing. Understanding why they appear in combination — and what clinicians do with that combination — is another matter. A result letter might show a reactive antibody result alongside a detected RNA result and a viral load figure and a genotype and an elevated ALT. Those four or five data points are not independent facts; they are a cluster that, read together by a clinician with knowledge of your history and circumstances, produces a clinical picture.
What a result letter cannot show is how long the virus has been present, whether the liver has experienced lasting change, or what the right next step looks like for a specific person. A letter showing a very high viral load is not, by itself, a more alarming letter than one showing a very low viral load. A letter showing a reactive antibody result and a not-detected RNA result is not, by itself, reassuring or worrying — it is incomplete without clinical context. The two tests and what each one finds is a fuller account of why both pieces of information are needed, and how they relate.
None of this is to say the letter doesn't matter — it does, and the language in it is real clinical language about real findings. It is to say that a letter is a document produced for clinical communication, and reading it without clinical training is a little like reading a structural engineer's survey report on a building: the words are English, and you can understand them individually, but their significance requires professional reading.
Before Your Appointment
If your result letter arrived before you have spoken to a clinician, a few things may be worth keeping in mind while you wait.
A result letter containing clinical-sounding words is not, on its own, a measure of how things stand. If words like "reactive," "detected," or a high-looking number prompted a wave of alarm, that is an understandable response — and also one that the letter itself cannot resolve. Only a conversation with your clinician can begin to resolve it, because only that conversation places the result in the context of your full picture.
If you find you have questions forming as you read the letter — about what a specific term means, about what happens next, about what a particular number implies — writing them down before your appointment is a practical way to make sure nothing slips in the moment. Questions worth writing down before a consultation is a piece on exactly that.
What the letter is telling you, in its formal language, is that a laboratory processed your sample, produced findings, and passed them to your clinical team. What happens with those findings is a clinical conversation, not a reading exercise.
General information only — not medical advice. Not affiliated with any clinic, laboratory, charity, campaign or pharmaceutical company. If you have questions about your own health, speak to a qualified clinician.